LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 nov. 2025, 21:06 UTC

Principalele dinamici ale pieței

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8 nov. 2025, 18:10 UTC

Câștiguri

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8 nov. 2025, 13:10 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8 nov. 2025, 12:00 UTC

Câștiguri

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8 nov. 2025, 10:30 UTC

Câștiguri

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8 nov. 2025, 03:50 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8 nov. 2025, 03:41 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8 nov. 2025, 03:07 UTC

Achiziții, Fuziuni, Preluări

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7 nov. 2025, 22:36 UTC

Câștiguri

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7 nov. 2025, 22:22 UTC

Câștiguri

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7 nov. 2025, 22:03 UTC

Câștiguri

Constellation Software 3Q Rev $2.95B >CSU.T

7 nov. 2025, 22:03 UTC

Câștiguri

Constellation Software 3Q Net $210M >CSU.T

7 nov. 2025, 22:03 UTC

Câștiguri

Constellation Software 3Q EPS $9.89 >CSU.T

7 nov. 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7 nov. 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7 nov. 2025, 20:59 UTC

Câștiguri

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7 nov. 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7 nov. 2025, 20:22 UTC

Câștiguri

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7 nov. 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7 nov. 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7 nov. 2025, 19:31 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7 nov. 2025, 19:17 UTC

Câștiguri

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7 nov. 2025, 19:09 UTC

Câștiguri

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7 nov. 2025, 19:08 UTC

Câștiguri

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7 nov. 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7 nov. 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7 nov. 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat